Q2 2014

Source filing unavailable

Q2 2014 · —

Revenue

$2.31B

+3.1% vs Q2 2013

Net Income

$19.88M

−31.2% vs Q2 2013

EPS Diluted

$0.32

−30.4% vs Q2 2013

Gross Profit$282,272,000+3.2%

Operating Income$37,101,000−25.9%

Operating Cash Flowderived

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$2.31B	$2.24B	$2.19B	$2.13B
Net Income	$19.88M	$28.87M	$30.11M	$29.16M
EPS Diluted	$0.32	$0.46	$0.48	$0.46

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR